Clinical Trial

Special Drug Use-results Survey for Long-term Use (Fostamatinib)

Name: Special Drug Use-results Survey for Long-term Use (Fostamatinib) — clinical trial record (NCT06757257)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.

Trial Details

NCT Number	NCT06757257
Lead Sponsor	Kissei Pharmaceutical Co., Ltd.
Conditions	Chronic Idiopathic Thrombocytopenic Purpura
Enrollment	149 participants
Start Date	2023-05-29
Primary Completion	2028-09-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-01-03